Rho-Kinase Activity and Cutaneous Vasoconstriction is Upregulated in Essential Hypertensive Humans

Overview

Journal Microvasc Res

Specialty Cardiology & Vascular Diseases

Date 2013 Mar 14

PMID 23481864

Citations 15

Authors

Caroline J Smith

Lakshmi Santhanam

Lacy M Alexander

Affiliations

Soon will be listed here.

Abstract

Essential hypertension (HT) is associated with endothelial dysfunction augmented vasoconstriction (VC) which may be secondary to increased Rho/Rho-Kinase (ROCK)-dependent mechanisms. Our aim was to assess the in vivo magnitude of cutaneous VC to local cooling as a ROCK specific stimulus, and in vitro evaluate ROCK activity in the skin from HT humans. Four microdialysis fibers were placed in the forearm of 9 pre- to stage I hypertensive (MAP: 106±3 mm Hg) and 11 normotensive (NT; 86±1 mm Hg) men and women: Ringers (control), 3mM fasudil (ROCK inhibited), 5mM yohimbine+1mM proprananol (α- and β-adrenoceptor inhibited; Y+P), Y+P+3mM fasudil (ROCK and adrenocepor inhibited). Skin blood flow was measured during local cooling (Tskl 24°C) and ROCK activity in the skin biopsy samples was determined with western blot. In vitro phosphorylated myosin phosphatase target subunit 1 (pMYPT-1)/ROCK was increased in the HT skin samples (p=0.0018). Functionally, no difference in basal vasomotor tone (Tskl 34°C) was observed between the groups (HT: 0.36±0.07 vs. NT: 0.31±0.07 CVC), nor at the control site during local cooling. Pre- to stage 1 hypertensives show greater ROCK-mediated vasoconstriction at early (1-5 min; HT: -0.8±0.2 versus NT: -0.3±0.2 ΔCVC baseline 1; P<0.0001) and late (36-40 min; HT: -0.9±0.1 versus NT: -0.5±0.2 ΔCVC baseline 1; P<0.0001) phases of local cooling. These data suggest that the magnitude of cutaneous vasoconstriction to local cooling does not differ in normotensive and pre- to stage I essential hypertensive humans; however, ROCK activity is increased and functional vasoconstriction is increasingly dependent upon Rho/ROCK mechanisms with essential hypertension.

Citing Articles

Vascular Health Triad in Humans With Hypertension-Not the Usual Suspects.

Ranadive S, Dillon G, Mascone S, Alexander L Front Physiol. 2021; 12:746278.

PMID: 34658930 PMC: 8517241. DOI: 10.3389/fphys.2021.746278.

Obstructive sleep apnoea and cardiovascular disease: a literature review.

Assallum H, Song T, Aronow W, Chandy D Arch Med Sci. 2021; 17(5):1200-1212.

PMID: 34522249 PMC: 8425247. DOI: 10.5114/aoms.2019.88558.

Cardiovascular diseases, cold exposure and exercise.

Ikaheimo T Temperature (Austin). 2018; 5(2):123-146.

PMID: 30377633 PMC: 6204981. DOI: 10.1080/23328940.2017.1414014.

Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway.

Li J, Zhao Y, Chang Y, Yang S, Guo Y, Ji E PLoS One. 2018; 13(4):e0195604.

PMID: 29641598 PMC: 5895022. DOI: 10.1371/journal.pone.0195604.

Acute lysyl oxidase inhibition alters microvascular function in normotensive but not hypertensive men and women.

Craighead D, Wang H, Santhanam L, Alexander L Am J Physiol Heart Circ Physiol. 2017; 314(3):H424-H433.

PMID: 29167120 PMC: 5899263. DOI: 10.1152/ajpheart.00521.2017.

References

Lauer T, Heiss C, Preik M, Balzer J, Hafner D, Strauer B . Reduction of peripheral flow reserve impairs endothelial function in conduit arteries of patients with essential hypertension. J Hypertens. 2005; 23(3):563-9. DOI: 10.1097/01.hjh.0000160213.40855.b7. View

Abularrage C, Sidawy A, Aidinian G, Singh N, Weiswasser J, Arora S . Evaluation of the microcirculation in vascular disease. J Vasc Surg. 2005; 42(3):574-81. DOI: 10.1016/j.jvs.2005.05.019. View

Bailey S, Eid A, Mitra S, Flavahan S, Flavahan N . Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation. Circ Res. 2004; 94(10):1367-74. DOI: 10.1161/01.RES.0000128407.45014.58. View

Smith C, Santhanam L, Bruning R, Stanhewicz A, Berkowitz D, Holowatz L . Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension. 2011; 58(5):935-42. PMC: 3209704. DOI: 10.1161/HYPERTENSIONAHA.111.178129. View

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G . 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25(6):1105-87. DOI: 10.1097/HJH.0b013e3281fc975a. View

Thompson C, Holowatz L, Kenney W . Cutaneous vasoconstrictor responses to norepinephrine are attenuated in older humans. Am J Physiol Regul Integr Comp Physiol. 2005; 288(5):R1108-13. DOI: 10.1152/ajpregu.00839.2004. View

Oi K, Shimokawa H, Hiroki J, Uwatoku T, Abe K, Matsumoto Y . Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase. Arterioscler Thromb Vasc Biol. 2004; 24(5):918-22. DOI: 10.1161/01.ATV.0000126678.93747.80. View

Kim J, Bugaj L, Oh Y, Bivalacqua T, Ryoo S, Soucy K . Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol (1985). 2009; 107(4):1249-57. PMC: 2763842. DOI: 10.1152/japplphysiol.91393.2008. View

Serne E, Gans R, Ter Maaten J, Tangelder G, Donker A, Stehouwer C . Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension. 2001; 38(2):238-42. DOI: 10.1161/01.hyp.38.2.238. View

10.

Kokubo Y, Kamide K, Okamura T, Watanabe M, Higashiyama A, Kawanishi K . Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita study. Hypertension. 2008; 52(4):652-9. DOI: 10.1161/HYPERTENSIONAHA.108.118273. View

11.

Vasan R, Larson M, Leip E, Evans J, ODonnell C, Kannel W . Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2002; 345(18):1291-7. DOI: 10.1056/NEJMoa003417. View

12.

Thompson-Torgerson C, Holowatz L, Flavahan N, Kenney W . Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am J Physiol Heart Circ Physiol. 2006; 292(4):H1700-5. DOI: 10.1152/ajpheart.01078.2006. View

13.

Hiroki J, Shimokawa H, Higashi M, Morikawa K, Kandabashi T, Kawamura N . Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol. 2004; 37(2):537-46. DOI: 10.1016/j.yjmcc.2004.05.008. View

14.

Cohuet G, Struijker-Boudier H . Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther. 2005; 111(1):81-98. DOI: 10.1016/j.pharmthera.2005.09.002. View

15.

Holowatz L, Thompson-Torgerson C, Kenney W . The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol (1985). 2007; 105(1):370-2. DOI: 10.1152/japplphysiol.00858.2007. View

16.

Rossi M, Carpi A, Galetta F, Franzoni F, Santoro G . The investigation of skin blood flowmotion: a new approach to study the microcirculatory impairment in vascular diseases?. Biomed Pharmacother. 2006; 60(8):437-42. DOI: 10.1016/j.biopha.2006.07.012. View

17.

Stewart J, Kohen A, Brouder D, Rahim F, Adler S, Garrick R . Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am J Physiol Heart Circ Physiol. 2004; 287(6):H2687-96. DOI: 10.1152/ajpheart.00287.2004. View

18.

Rizzoni D, Porteri E, Boari G, De Ciuceis C, Sleiman I, Muiesan M . Prognostic significance of small-artery structure in hypertension. Circulation. 2003; 108(18):2230-5. DOI: 10.1161/01.CIR.0000095031.51492.C5. View

19.

Eto M, Barandier C, Rathgeb L, Kozai T, Joch H, Yang Z . Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res. 2001; 89(7):583-90. DOI: 10.1161/hh1901.097084. View

20.

Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K . Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res. 2003; 92(4):411-8. DOI: 10.1161/01.RES.0000059987.90200.44. View